The global inhalation anesthesia market is expected to reach $1.5 billion by 2022, according to a report by Grand View Research.
Here are five trends:
1. Key factors contributing to its rapid growth include increasing geriatric population prone to chronic diseases as well as the increasing number of emergency cases.
2. In 2014, the North America inhalation anesthesia market accounted for nearly 43 percent of the total global revenue.
3. Asia Pacific is the fastest growing regional market.
4. The sevoflurane segment was the largest product group, accounting for over 70 percent of the demand in 2014. However, isoflurane is expected to witness nearly 12 percent growth from 2014 to 2022.
5. Key players in the market include Abbvie and Baxter.